Fact Sheet
IQVIA Use By Indication (UBI)
Indication split tracking and insights for the autoimmune biologics (AIB) market across European markets, for precise decision making and accelerating performance.
Feb 10, 2021
Download

IQVIA Use by Indication (UBI) is a high precision, best of breed solution for tracking performance in the AIB market for EU4 (France, Germany, Italy, Spain) and Belgium, Ireland, Netherlands and United Kingdom. It delivers the most precise volume and value of AIB drug usage at indication and specialty level.

Nurse with baby delivery room

Market Intelligence Solutions

Powered by IQVIA's Information Offerings, our healthcare market intelligence solutions provides key summary data and actionable insights covering medicines and healthcare products in primary care, secondary care and supply chains across the UK, NHS and healthcare sectors.
Contact Us